Program

  Wednesday, October 14, 2020

  Thursday, October 15, 2020

  Friday, October 16, 2020

  Saturday, October 17, 2020



  Wednesday, October 14, 2020

[« back]
• Online Room
Time Activity
6:15pm-6:30pmOpening Ceremony
Presenter: FERNANDO CORONETTI GOMES DA ROCHA (Brazil/SP)
Presenter: CARLOS ROBERTO DE MELLO RIEDER (Brazil/RS)
Presenter: JEFFERSON BECKER (Brazil/RS)
6:30pm-8pmSession: Advances in neuroimaging
Chairperson: FERNANDO FARIA ANDRADE FIGUEIRA (Brazil/RJ)
Chairperson: DIOGO HADDAD SANTOS (Brazil/SP)
Connectivity, cognition and fatigue in MS: How are they related?
Speaker: ANDREAS HESS (Germany)
Clinical use of PET-MRI in demyelinating diseases
Speaker: DANIELE DE PAULA FARIA (Brazil/SP)
Myelin imaging: New frontiers of quantitative imaging
Speaker: CAROLINA DE MEDEIROS RIMKUS (Brazil/SP)
Discussion
8pm-8:40pmPharma symposium: ROCHE
Expert interview: What´s next in NMOSD?

Chairperson: DOUGLAS KAZUTOSHI SATO (Brazil/RS)
Speaker: MICHAEL LEVY (United States)
8:40pm-9pmBreak
9pm-10pmAluízio Marques Lecture
Chairperson: VICTOR FERNANDO HAMUY DIAZ DE BEDOYA (Paraguay)
Chairperson: OSVALDO J. M. NASCIMENTO (Brazil/RJ)
MS and NMOSD in COVID-19 Era
Speaker: XAVIER MONTALBAN (Spain)
Comments by: OSVALDO J. M. NASCIMENTO (Brazil/RJ)

  Thursday, October 15, 2020

[« back]
• Online Room
Time Activity
08am-10amScientific session: CTRIMS Session
Chairperson: DAGOBERTO CALLEGARO (Brazil/SP)
Chairperson: MARCO LANA-PEIXOTO (Brazil/MG)
Silent progression in RRMS: clinical and cognitive aspects
Speaker: ALFREDO DAMASCENO (Brazil/SP)
Genetics of multiple sclerosis: A review
Speaker: BERNHARD HEMMER (Germany)
Microbiota and inmunonutrition in NMOSD
Speaker: CARLOS NAVAS (Colombia)
Therapy of NMOSD: an update
Speaker: KAZUO FUJIHARA (Japan)
Preditors of outcome in pediatric NMOSD
Speaker: BIANCA WEINSTOCK-GUTTMAN (United States)
Discussion
10am-11amPharma symposium: BIOGEN
11am-12:30pmScientific session: Translational symposium in Demyelinating Diseases
Chairperson: ALESSANDRO DOS SANTOS FARIAS (Brazil/SP)
Chairperson: MONICA KONCKE FIUZA PAROLIN (Brazil/PR)
Multiple Sclerosis: does translational neuroimmunology exist?
Speaker: JEAN PIERRE SCHATZMANN PERON (Brazil/SP)
B cell directed immunotherapy of multiple sclerosis: From bench to bedside
Speaker: BERNHARD HEMMER (Germany)
In vivo imaging system as a robust and promising tool for neuroimmunology
Speaker: GUSTAVO MENEZES (Brazil/MG)
Discussion
6:30pm-8pmScientific session: Top 10 of the year: how the best papers impact our practice
Presenter: ALFREDO DAMASCENO (Brazil/SP)
Presenter: FERNANDO CORONETTI GOMES DA ROCHA (Brazil/SP)
Panel

Debater: VICTOR RIVERA (United States)
Debater: BIANCA WEINSTOCK-GUTTMAN (United States)
Debater: FRED LUBLIN (United States)
8pm-8:40pmPharma symposium: MERCK
Real-life responses to COVID-19 in Mavenclad patients

Chairperson: JEFFERSON BECKER (Brazil/RS)
Speaker: DANIEL SELCHEN (Canada)
8:40pm-9pmBreak
9pm-10:30pmScientific session: LACTRIMS
Chairperson: CARLOS NAVAS (Colombia)
Chairperson: CLAUDIA CRISTINA FERREIRA VASCONCELOS (Brazil/RJ)
Evolutionary Assessment Criteria for Neurocognitive Batteries in the LATAM population
Speaker: SANDRA VANOTTI (Argentina)
Nutrition and Multiple Sclerosis
Speaker: CARLOS NAVAS (Colombia)
Escalation Vs Induction
Speaker: VICTOR FERNANDO HAMUY DIAZ DE BEDOYA (Paraguay)
Discussion

  Friday, October 16, 2020

[« back]
• Online Room
Time Activity
08am-09:30amScientific session: Epidemiology of Neuromyelitis Optica Spectrum Disorders
Chairperson: PAULO PEREIRA CHRISTO (Brazil/MG)
Chairperson: NISE ALESSANDRA DE CARVALHO SOUSA CASTRO (Brazil/AM)
The World epidemiology of NMOSD
Speaker: NASRIN ASGARI (Denmark)
NMOSD in Brazil
Speaker: MARCO LANA-PEIXOTO (Brazil/MG)
Causes and risk of death in NMOSD
Speaker: MICHAEL LEVY (United States)
Discussion
09:30am-10:10amPharma symposium: SANOFI
10:10am-10:30amBreak
10:30am-12pmScientific session: Neuromyelitis optica spectrum disorders – Part I
Chairperson: VANESSA DACCACH MARQUES (Brazil/SP)
Chairperson: CARLOS BERNARDO TAUIL (Brazil/DF)
Pathology and pathophysiology of NMOSD
Speaker: KAZUO FUJIHARA (Japan)
Visual involvement in NMOSD
Speaker: FRIEDEMANN PAUL (Germany)
Immunopathophysiology of MOG-related disorders
Speaker: FELIPE VON GLEHN (Brazil/DF)
Discussion
6:30pm-8pmScientific session: Neuromyelitis optica spectrum session disorders - Part II
Chairperson: RODRIGO BARBOSA THOMAZ (Brazil/SP)
Chairperson: ANA CLAUDIA PICCOLO (Brazil/SP)
Differential diagnosis of transverse myelitis
Speaker: SAMIRA LUISA APOSTOLOS PEREIRA (Brazil/SP)
Biomarkers in diagnosis of demyelinating diseases of the CNS
Speaker: DOUGLAS KAZUTOSHI SATO (Brazil/RS)
Monoclonal Ab in the treatment of NMOSD: Why? When? Which?
Speaker: MICHAEL LEVY (United States)
Discussion
8pm-8:30pmPharma symposium: FLEURY
Imaging tools useful in the diagnosis and follow-up of demyelinating diseases: what can we already apply in the clinical-radiological routine?

Speaker: CAROLINA DE MEDEIROS RIMKUS (Brazil/SP)
8:30pm-9pmBreak
9pm-10:30pmScientific session: LACTRIMS
Chairperson: VICTOR RIVERA (United States)
Chairperson: RENAN DOMINGUES (Brazil/SP)
Differential diagnosis in MS
Speaker: JULIANA MACHADO SANTIAGO SANTOS AMARAL (Brazil/MG)
Are the frontiers of the diagnosis for MS understood in Latin America?
Speaker: VICTOR RIVERA (United States)
Biomarkers of evolution and prognosis in CSF
Speaker: CARLOS OEHNINGER (Uruguay)
Discussion

  Saturday, October 17, 2020

[« back]
• Online Room
Time Activity
08am-10amEuropean Charcot Foundation Symposium: PRO Value and Limitations
Chairperson: XAVIER MONTALBAN (Spain)
Chairperson: MARCO LANA-PEIXOTO (Brazil/MG)
Methodological aspects: Value and limitations
Speaker: XAVIER MONTALBAN (Spain)
PRO: The patient's perspective
Speaker: GIAMPAOLO BRICHETTO (Italy)
PROMS Initiative
Speaker: HANS PETER HARTUNG (Germany)
Role of PRO in treatment assessment
Speaker: JEFFERSON BECKER (Brazil/RS)
Discussion
10am-10:40amPharma symposium: NOVARTIS
11am-1pmHarvard Medical School Symposium
Chairperson: MARIA LUCIA BRITO (Brazil/PE)
Chairperson: JULIANA MACHADO SANTIAGO SANTOS AMARAL (Brazil/MG)
Digital phenotyping and telemedicine for NMOSD, MOG and MS
Speaker: MARCELO MATIELLO (United States)
The future of clinical trials in AQP4 and MOG diseases
Speaker: MICHAEL LEVY (United States)
Best treatment strategies for MOG disease: Acute attacks and immunosuppression
Speaker: ANU JACOB (United Kingdom)
Updates in PML and MS
Speaker: RAFAEL PATERNO CASTELLO DIAS CARNEIRO (Brazil/SP)
Misdiagnosis of MS: Common clinical pitfalls
Speaker: GUSTAVO TOMASI (Brazil)
Diagnosis and treatment of patients with spinal cord MS phenotype
Speaker: MANUELA DE OLIVEIRA FRAGOMENI (Brazil/DF)
Can MS and MOG disease co-exist?
Speaker: LUIS FERNANDO GUIMARAES (Brazil/RJ)
Discussion
1pm-1:15pmClosing Remarks: Closing remarks and invitation to BCTRIMS 22nd Annual Meeting, 2021
Presenter: FERNANDO CORONETTI GOMES DA ROCHA (Brazil/SP)
Presenter: JEFFERSON BECKER (Brazil/RS)
Presenter: DOUGLAS KAZUTOSHI SATO (Brazil/RS)





Management


Travel Agency


Support by


Gold Sponsors


Silver Sponsors


Bronze Sponsors